Advenion Biotech

Advenion Biotech is a Cambridge-based biotechnology company founded in 2023 as a spin-off from Euronutra, a Spanish firm with over 30 years of experience in natural ingredient research. The company focuses on developing and manufacturing high-purity active pharmaceutical ingredients (APIs) derived from natural sources, particularly carob pods, using a proprietary solvent-free extraction platform. Advenion's therapeutic pipeline targets chronic disabling conditions such as infertility, neurodegeneration (including Alzheimer's disease), affective disorders, and metabolic imbalances like diabetes. By leveraging a translational research model and strategic academic collaborations, the company aims to provide sustainable, pharmaceutical-grade solutions for high unmet medical needs. Advenion maintains its headquarters in the Kendall Square biotech hub while utilizing its European roots for research and manufacturing excellence.